HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.
2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Research and Clinical Trials
Cancer Research and Clinical Trials
- Translational Research: Bridging the gap between laboratory findings and clinical applications.
- Clinical Trial Design: Innovations in trial methodologies and patient recruitment.
- Regulatory Challenges: Navigating the approval process for new therapies.
- Patient Involvement in Research: Ethical considerations and patient advocacy in research.
Cancer research and clinical trials play a crucial role in advancing our understanding of cancer and improving treatment outcomes. Through research, scientists explore the molecular and genetic basis of cancer, enabling the development of targeted therapies that are more effective and less harmful than traditional treatments. Clinical trials are essential for testing new drugs, therapies, and treatment protocols in real-world settings, helping to determine their safety and efficacy. Participants in clinical trials contribute to groundbreaking discoveries that can potentially save lives. As cancer research continues to evolve, it holds promise for finding more personalized treatments and, ultimately, a cure.
Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States CIOC 2026 Speakers
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Eleni Petsalaki
University of Crete, Greece
Miri Cohen
University of Haifa, IsraelSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China